Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Poissy

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 3, 2022
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohortJade Ghosn, Delphine Bachelet, Marine Livrozet, et al.
British Journal of Clinical Pharmacology|January 21, 2023
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortiaVida Terzić, Léa Levoyer, Mélanie Figarella, et al.
Clinical & Translational Immunology|December 30, 2020
Severe SARS-CoV-2 patients develop a higher specific T-cell responseJulie Demaret, Guillaume Lefèvre, Fanny Vuotto, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2021
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohortNadège Néant, Guillaume Lingas, Quentin Le Hingrat, et al.
Ebiomedicine|September 15, 2023
Long-COVID cognitive impairments and reproductive hormone deficits in men may stem from GnRH neuronal deathFlorent Sauve, Sreekala Nampoothiri, Sophie A Clarke, et al.
Critical Care (London, England)|August 24, 2023
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISGDaniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, et al.
Annals of Medicine|June 14, 2025
Mortality of <i>Pneumocystis jirovecii</i> pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISGDaniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, et al.
Scientific Reports|April 24, 2025
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trialDavid M Smadja, Clément R Massonnaud, Aurélien Philippe, et al.
Ebiomedicine|December 28, 2024
Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trialHans-Kittil Viermyr, Kristian Tonby, Erica Ponzi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 3, 2022
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohortJade Ghosn, Delphine Bachelet, Marine Livrozet, et al.
British Journal of Clinical Pharmacology|January 21, 2023
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortiaVida Terzić, Léa Levoyer, Mélanie Figarella, et al.
Clinical & Translational Immunology|December 30, 2020
Severe SARS-CoV-2 patients develop a higher specific T-cell responseJulie Demaret, Guillaume Lefèvre, Fanny Vuotto, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2021
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohortNadège Néant, Guillaume Lingas, Quentin Le Hingrat, et al.
Ebiomedicine|September 15, 2023
Long-COVID cognitive impairments and reproductive hormone deficits in men may stem from GnRH neuronal deathFlorent Sauve, Sreekala Nampoothiri, Sophie A Clarke, et al.
Critical Care (London, England)|August 24, 2023
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISGDaniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, et al.
Annals of Medicine|June 14, 2025
Mortality of <i>Pneumocystis jirovecii</i> pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISGDaniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, et al.
Scientific Reports|April 24, 2025
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trialDavid M Smadja, Clément R Massonnaud, Aurélien Philippe, et al.
Ebiomedicine|December 28, 2024
Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trialHans-Kittil Viermyr, Kristian Tonby, Erica Ponzi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.
Pageof 9